Sotigalimab
Sotigalimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Sotigalimab is under investigation in clinical trial NCT03123783 (CD40 Agonistic Antibody APX005M in Combination With Nivolumab).
| Trade Name | Sotigalimab |
| Generic | Sotigalimab |
| Sotigalimab Other Names | Sotigalimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Sotigalimab
